Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 10 | 2024 | 120 | 3.990 |
Why?
|
| Alzheimer Disease | 11 | 2024 | 565 | 3.080 |
Why?
|
| Exosomes | 3 | 2019 | 44 | 1.770 |
Why?
|
| Memory Disorders | 3 | 2020 | 111 | 1.400 |
Why?
|
| Locus Coeruleus | 3 | 2022 | 55 | 0.910 |
Why?
|
| Amyloid beta-Peptides | 6 | 2023 | 191 | 0.760 |
Why?
|
| Extracellular Vesicles | 2 | 2019 | 21 | 0.710 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2020 | 9 | 0.710 |
Why?
|
| Adrenergic Neurons | 1 | 2019 | 7 | 0.700 |
Why?
|
| Endocytosis | 1 | 2019 | 113 | 0.650 |
Why?
|
| Hippocampus | 2 | 2020 | 471 | 0.570 |
Why?
|
| Biomarkers | 3 | 2022 | 1593 | 0.530 |
Why?
|
| Neuroimaging | 1 | 2016 | 122 | 0.480 |
Why?
|
| tau Proteins | 3 | 2020 | 61 | 0.480 |
Why?
|
| Cognition Disorders | 1 | 2016 | 342 | 0.420 |
Why?
|
| Brain | 7 | 2024 | 2176 | 0.400 |
Why?
|
| Mice, Transgenic | 6 | 2022 | 1033 | 0.390 |
Why?
|
| Neuropathology | 2 | 2023 | 6 | 0.350 |
Why?
|
| Animals | 13 | 2023 | 20881 | 0.340 |
Why?
|
| Plaque, Amyloid | 2 | 2023 | 31 | 0.270 |
Why?
|
| Mice | 9 | 2022 | 8474 | 0.240 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 2550 | 0.230 |
Why?
|
| Neurofibrillary Tangles | 1 | 2023 | 8 | 0.220 |
Why?
|
| Designer Drugs | 2 | 2019 | 7 | 0.210 |
Why?
|
| Two-Dimensional Difference Gel Electrophoresis | 2 | 2012 | 2 | 0.200 |
Why?
|
| Maze Learning | 2 | 2020 | 138 | 0.200 |
Why?
|
| Humans | 16 | 2024 | 68618 | 0.200 |
Why?
|
| Cognitive Dysfunction | 2 | 2022 | 176 | 0.200 |
Why?
|
| Amyloidogenic Proteins | 1 | 2020 | 4 | 0.190 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2022 | 106 | 0.190 |
Why?
|
| Saliva | 1 | 2021 | 142 | 0.190 |
Why?
|
| Marijuana Smoking | 1 | 2021 | 108 | 0.180 |
Why?
|
| Bacteria | 1 | 2021 | 193 | 0.180 |
Why?
|
| Proteins | 3 | 2012 | 474 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 174 | 0.170 |
Why?
|
| Cell Communication | 1 | 2019 | 116 | 0.160 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 597 | 0.160 |
Why?
|
| Macrophages | 1 | 2021 | 647 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2022 | 239 | 0.150 |
Why?
|
| Male | 7 | 2022 | 37321 | 0.140 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2013 | 306 | 0.140 |
Why?
|
| Peptide Fragments | 2 | 2016 | 483 | 0.140 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2015 | 2 | 0.130 |
Why?
|
| Thioctic Acid | 1 | 2015 | 6 | 0.130 |
Why?
|
| Electron Transport Complex III | 1 | 2015 | 5 | 0.130 |
Why?
|
| Proteomics | 3 | 2012 | 246 | 0.130 |
Why?
|
| Proteome | 2 | 2013 | 87 | 0.130 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2015 | 10 | 0.130 |
Why?
|
| Clozapine | 1 | 2015 | 46 | 0.120 |
Why?
|
| Image Enhancement | 1 | 2014 | 143 | 0.120 |
Why?
|
| Neurons | 1 | 2019 | 881 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2015 | 382 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2013 | 94 | 0.110 |
Why?
|
| Apolipoprotein E3 | 1 | 2012 | 7 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 89 | 0.110 |
Why?
|
| Apolipoprotein E4 | 1 | 2012 | 31 | 0.110 |
Why?
|
| Ubiquitin | 1 | 2013 | 74 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 237 | 0.110 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 247 | 0.100 |
Why?
|
| Wnt1 Protein | 1 | 2011 | 9 | 0.100 |
Why?
|
| beta Catenin | 1 | 2011 | 73 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2015 | 718 | 0.100 |
Why?
|
| Pericardium | 1 | 2011 | 97 | 0.090 |
Why?
|
| Regeneration | 1 | 2011 | 105 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2008 | 139 | 0.090 |
Why?
|
| Young Adult | 2 | 2022 | 5717 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 284 | 0.090 |
Why?
|
| Middle Aged | 4 | 2022 | 21147 | 0.080 |
Why?
|
| Aging | 1 | 2014 | 911 | 0.080 |
Why?
|
| Cognition | 2 | 2022 | 513 | 0.080 |
Why?
|
| Peptide Mapping | 1 | 2007 | 39 | 0.080 |
Why?
|
| Markov Chains | 1 | 2008 | 133 | 0.070 |
Why?
|
| Heart | 1 | 2011 | 850 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2011 | 902 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 807 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2007 | 159 | 0.070 |
Why?
|
| Female | 4 | 2022 | 38074 | 0.060 |
Why?
|
| Peptides | 1 | 2008 | 455 | 0.060 |
Why?
|
| Adolescent | 1 | 2016 | 8912 | 0.060 |
Why?
|
| Biological Specimen Banks | 1 | 2024 | 38 | 0.060 |
Why?
|
| Europe | 1 | 2024 | 196 | 0.060 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2013 | 50 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2013 | 234 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2011 | 2689 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 4848 | 0.050 |
Why?
|
| Aged | 3 | 2022 | 14862 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 134 | 0.050 |
Why?
|
| DNA, Ribosomal | 1 | 2021 | 59 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 85 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 150 | 0.050 |
Why?
|
| Microglia | 1 | 2022 | 143 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 208 | 0.050 |
Why?
|
| Autopsy | 1 | 2020 | 56 | 0.050 |
Why?
|
| Phylogeny | 1 | 2021 | 197 | 0.050 |
Why?
|
| Pericytes | 1 | 2022 | 81 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2022 | 330 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2022 | 211 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2673 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 2791 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1553 | 0.040 |
Why?
|
| Cell Line | 1 | 2021 | 1752 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1293 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2022 | 640 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2279 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 2358 | 0.030 |
Why?
|
| Algorithms | 2 | 2014 | 1196 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2015 | 23 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2014 | 134 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 99 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 248 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 260 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 79 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 314 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2013 | 7 | 0.030 |
Why?
|
| Chaperonin 60 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Tropomyosin | 1 | 2013 | 4 | 0.030 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2013 | 13 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 102 | 0.030 |
Why?
|
| Adult | 2 | 2022 | 21403 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 113 | 0.030 |
Why?
|
| Creatine Kinase | 1 | 2012 | 46 | 0.030 |
Why?
|
| Solubility | 1 | 2012 | 134 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 35 | 0.030 |
Why?
|
| Analytic Sample Preparation Methods | 1 | 2012 | 2 | 0.030 |
Why?
|
| Lipoylation | 1 | 2012 | 8 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 2012 | 42 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 246 | 0.030 |
Why?
|
| Trypsin | 1 | 2012 | 64 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 144 | 0.020 |
Why?
|
| Transfection | 1 | 2013 | 782 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 201 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 85 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 358 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 621 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 541 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 643 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2011 | 135 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1027 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 786 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1040 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 567 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 376 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 442 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 434 | 0.020 |
Why?
|
| Fibrosis | 1 | 2011 | 371 | 0.020 |
Why?
|
| Wound Healing | 1 | 2011 | 260 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2077 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 682 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 1200 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 2083 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 329 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 5300 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2008 | 384 | 0.020 |
Why?
|